jianke.com
Edit

jianke.com

http://www.jianke.com/
Last activity: 27.08.2025
Active
Categories: B2CBrandHealthTechMedtechOnlinePlatformProductService
Jianke is the largest online pharmacy and healthcare services platform in China, offering 680,000 SKUs and a robust set of healthcare advisory services. Founded in 2006, Guangzhou-based Jianke focuses on the B2C sector and has served over 100 million customers.
Website visits
462.5K /mo.
Mentions
30
Employees: 501-1000
Total raised: $130M
Founded date: 2006

Investors 4

Funding Rounds 1

DateSeriesAmountInvestors
04.09.2018Series B$130M-

Mentions in press and media 30

DateTitleDescription
27.08.2025Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base ExpandHONG KONG, Aug. 27, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, reported a profitable first half of 2025, supported by an expanding us...
18.07.2025Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health ManagementBEIJING, July 18, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcar...
03.07.2025Fangzhou Tops China's App Store Chart for Healthcare AppsGUANGZHOU, China, July 3, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, earned the top spot in the June 2025 China AppStore Healthcare TOP100 Free...
13.05.2025Fangzhou CEO Honored at 2025 VBEF Conference as Company Showcases AI Medical InnovationsSUZHOU, China, May 13, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, participated in the prestigious 2025 VBEF Future Healthcare and Medicine Conf...
06.05.2025Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its PlatformGUANGZHOU, China, May 6, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced the availability of Otsuka Pharmaceutical's third-generation tyro...
17.04.2025Fangzhou Launches Partnership for "AI + Hepatitis Prevention & Control Training Center" at the Greater Bay Area International Liver Disease ForumGUANGZHOU, China, April 17, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven healthcare solutions, partnered with the Guangdong Provincial Liver Disease Institute at the ...
14.04.2025Fangzhou Presents AI-Driven Healthcare Ecosystem at Guangzhou Biotech Innovation SalonGUANGZHOU, China, April 14, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leading Internet healthcare solution provider, participated in the "AI Empowers Biopharma" exchange pan...
10.04.2025Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI ModelsGUANGZHOU, China, April 10, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leading Internet healthcare solution provider, emerged as the sole digital health innovator invited to the Modern...
03.04.2025Fangzhou Designated as a 2024 National High-Tech Enterprise Amid Record GrowthBEIJING, April 3, 2025 /PRNewswire/ -- Beijing Fangyixing Information Technology Co., Ltd. ("Fangyixing"), a subsidiary of China's leading Internet healthcare solutions provider Fangzhou Inc. ("Fangzhou" or the "Com...
28.03.2025Fangzhou Inc. Named Among Guangzhou's Top AI Innovators for Intelligent Healthcare PlatformGUANGZHOU, China, March 28, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, has been named to the 2024 Guangzhou Artificial Intelligence Innovation ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In